Investors










Overview

Medicure was founded in 1997 and became a public company in November 1999. The company trades under the symbol MPH on the TSX Venture Exchange. As a U.S focused Specialty Pharma company with established sales of Aggrastat, Medicure carefully monitors opportunities within its own pipeline of products and possible acquisitions of related pharma companies in order to realize long term value.





Financial Reports

Quarterly and Annual financial reports will be posted below after release.

Effective Dec 18, 2014 the Fiscal Year End was changed to December 31 from May 31.





Conference Call

Q2 – June 30, 2017